(Q43696572)

25 November 2017

title

Capillary electrophoretic separation of protease inhibitors used in human immunodeficiency virus therapy (English)

1 reference

25 November 2017

Gutleben W

1

1 reference

25 November 2017

Tuan ND

2

1 reference

25 November 2017

Stoiber H

3

1 reference

25 November 2017

Dierich MP

4

1 reference

25 November 2017

Sarcletti M

5

1 reference

25 November 2017

Zemann A

6

1 reference

25 November 2017

language of work or name

English

0 references

publication date

1 July 2001

1 reference

Journal of Chromatography

25 November 2017

number of pages

8

1 reference

based on heuristic

inferred from page(s)

published in

1 reference

25 November 2017

volume

922

1 reference

25 November 2017

issue

1-2

1 reference

25 November 2017

page(s)

313-320

1 reference

Immunopathology as a result of highly active antiretroviral therapy in HIV-1-infected patients

25 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2900890-1

Randomised placebo-controlled trial of ritonavir in advanced HIV-1 disease. The Advanced HIV Disease Ritonavir Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2900890-1

Quantifying residual HIV-1 replication in patients receiving combination antiretroviral therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2900890-1

In vitro screening of nucleoside analog combinations for potential use in anti-HIV therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2900890-1

Simultaneous quantitative determination of the HIV protease inhibitors amprenavir, indinavir, nelfinavir, ritonavir and saquinavir in human plasma by ion-pair high-performance liquid chromatography with ultraviolet detection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2900890-1

Rapid quantification of indinavir in human plasma by high-performance liquid chromatography with ultraviolet detection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2900890-1

Simultaneous determination of ritonavir and saquinavir, two human immunodeficiency virus protease inhibitors, in human serum by high-performance liquid chromatography.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2900890-1

Determination of saquinavir in human plasma, saliva, and cerebrospinal fluid by ion-pair high-performance liquid chromatography with ultraviolet detection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2900890-1

High-performance liquid chromatographic determination of ritonavir in human plasma, cerebrospinal fluid and saliva.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2900890-1

High-performance liquid chromatographic method for the simultaneous determination of HIV-1 protease inhibitors indinavir, saquinavir and ritonavir in plasma of patients during highly active antiretroviral therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2900890-1

Simultaneous determination of the HIV protease inhibitors indinavir, amprenavir, saquinavir, ritonavir, nelfinavir and the non-nucleoside reverse transcriptase inhibitor efavirenz by high-performance liquid chromatography after solid-phase extractio

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2900890-1

Determination of indinavir in human cerebrospinal fluid and plasma by solid-phase extraction and high-performance liquid chromatography with column switching

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2900890-1

Determination of human immunodeficiency virus-1 protease inhibitors in patient serum using free solution capillary zone electrophoresis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2900890-1

Preformulation studies of a novel HIV protease inhibitor, AG1343.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2900890-1

The steady-state plasma pharmacokinetics of indinavir alone and in combination with a low dose of ritonavir in twice daily dosing regimens in HIV-1-infected individuals

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2900890-1

Simple high-performance liquid chromatographic determination of the protease inhibitor indinavir in human plasma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2900890-1

inferred from DOI database lookup

7 January 2021

based on heuristic

Sensitive liquid chromatographic assay for amprenavir, a human immunodeficiency virus protease inhibitor, in human plasma, cerebrospinal fluid and semen

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2900890-1

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0021-9673(01)00890-1

1 reference

25 November 2017

1 reference